Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(394)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Aug 29, 2023 4:03pm
BIOV OUR SLEEPING GIANT HAS AWAKEN$$ GREAT DAY! over 1.4 MIL
but also some shannigans goings on TD & ANON..hmmm Recent Trades - Last 10 of 70 More trades... Time ET Ex Price Change
...more
(459)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Aug 25, 2023 3:11pm
An out-of-favour biotech stock developing next-gen vaccines
https://stockhouse.com/news/newswire/2023/08/25/an-out-favour-biotech-stock-developing-next-gen-cancer-vaccines
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(24)
•••
Appreciation777
X
View Profile
View Bullboard History
Comment by
Appreciation777
on Jul 28, 2023 7:39pm
RE:Roll it back 1 for 20
Great potentiality here for BIOV, once they roll it back. They may not have to do 1 for 20 as there is 105 Million outstanding only I understand and insiders own most of the stock. perhaps 1 for
...more
(16)
•••
Magnum2
X
View Profile
View Bullboard History
Post by
Magnum2
on Jul 11, 2023 4:13pm
Roll it back 1 for 20
just a matter of time. I made some great money while they had some opportunities, but the days of free money are gone. GLTA
(77)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jun 14, 2023 7:22pm
BioVaxys Announces Sale of TAET Software Co
BioVaxys Announces Sale of TAET Software Co by @newsfile on 14 Jun 2023, 17:28 Vancouver, British Columbia--(Newsfile Corp. - June 14, 2023) - BioVaxys
...more
(394)
•••
moneywagon
X
View Profile
View Bullboard History
Comment by
moneywagon
on Apr 19, 2023 2:00pm
RE:BIOV 2DAY NEWSWIRE~100% IT'S A BEAR TRAP BROKERS PRESSURE
sorry correction "mdma" not mda....sorry again type "O"
(394)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Apr 19, 2023 1:28pm
BIOV 2DAY NEWSWIRE~100% IT'S A BEAR TRAP BROKERS PRESSURE
the ASk heay heavy all the way down. Gunna see a NEW 52 WEEK LOW while the Brokers load up....to get your shares. LOOK at the pressure on that ASk sp down here!! Ya ya I read all the post
...more
(77)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Apr 19, 2023 1:13pm
BIOV DETAILS THE VALUE IN ENGAGING MAXIM FOR U S LISTING
BioVaxys details shareholder value with retention of Maxim to achieve US stock exchange listing by @thenewswire on 19 Apr 2023, 13:01 (NewsDirect)
...more
(394)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Apr 19, 2023 12:13pm
BIOV CEO INTERVIEW JAMES PASSIN
Hey DOXIE just sharing, did you see the interview?? Anon has been on a continuous dump for over a month now. The good side is every sell is a strong hold share holder. Not my first rodeo (pharma
...more
(77)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Apr 17, 2023 10:31am
BIOV: RETAINS MAXIM GROUP AS FINANCIAL ADVISOR & INV BANKER
(I think this is a good NR, SOMETHINGS IS BREWING) BIOVAXYS RETAINS MAXIM GROUP AS FINANCIAL ADVISOR AND INVESTMENT BANKER by @newswire on 17 Apr 2023, 08:00 VANCOUVER, British
...more
(15)
•••
1DoxieDollar
X
View Profile
View Bullboard History
Post by
1DoxieDollar
on Apr 13, 2023 3:54pm
Papilocare in Journal of National Science Foundation
https://www.pnas.org/doi/10.1073/pnas.2304645120 From Twitter, there are 6 new clinical studies on Papilocare being presented next week at the lInternational Papillomavirus Society conference in
...more
(77)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Apr 12, 2023 8:42am
BIOV: CFO CHANGE
BIOVAXYS ANNOUNCES APPOINTMENT OF CFO AND BOARD CHANGES by @newswire on 12 Apr 2023, 08:35 VANCOUVER, BC, April 12, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV)
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 12, 2023 8:35am
New Press Release - BIOVAXYS ANNOUNCES APPOINTMENT OF CFO AND BOARD CHANGES
VANCOUVER, BC, April 12, 2023 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce that Dasha Enenko has been appointed as its Chief Financial Officer ("CFO"). Dasha is a Chartered Professional Accountant with over 12...
read article.
(15)
•••
1DoxieDollar
X
View Profile
View Bullboard History
Post by
1DoxieDollar
on Apr 04, 2023 4:10pm
Tweet from BIOV: Expanded / enhanced production capabilities
https://www.polyplus-transfection.com/news/sartorius-acquire-polyplus/ "Congratulations to our biomanufacturing partner Polyplus/BioElpida for its acquisition by Sartorius Stedim Biotech for €2
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth